nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—Diphenhydramine—atopic dermatitis	0.397	1	CrCtD
Doxepin—ORM1—Tacrolimus—atopic dermatitis	0.0297	0.129	CbGbCtD
Doxepin—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.0266	0.104	CrCrCtD
Doxepin—CHRM2—Dimenhydrinate—atopic dermatitis	0.0253	0.11	CbGbCtD
Doxepin—HRH1—Dimenhydrinate—atopic dermatitis	0.0231	0.1	CbGbCtD
Doxepin—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0209	0.0817	CrCrCtD
Doxepin—KCNH2—Loratadine—atopic dermatitis	0.0191	0.083	CbGbCtD
Doxepin—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0186	0.0726	CrCrCtD
Doxepin—Cyclobenzaprine—Diphenhydramine—atopic dermatitis	0.0163	0.0635	CrCrCtD
Doxepin—Dimetindene—Diphenhydramine—atopic dermatitis	0.0158	0.0617	CrCrCtD
Doxepin—Doxylamine—Diphenhydramine—atopic dermatitis	0.0149	0.0584	CrCrCtD
Doxepin—Amitriptyline—Diphenhydramine—atopic dermatitis	0.0146	0.0569	CrCrCtD
Doxepin—Tripelennamine—Diphenhydramine—atopic dermatitis	0.0135	0.0528	CrCrCtD
Doxepin—Trimipramine—Diphenhydramine—atopic dermatitis	0.0132	0.0516	CrCrCtD
Doxepin—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.0126	0.0494	CrCrCtD
Doxepin—Dimetacrine—Diphenhydramine—atopic dermatitis	0.0126	0.0494	CrCrCtD
Doxepin—Pheniramine—Diphenhydramine—atopic dermatitis	0.0124	0.0483	CrCrCtD
Doxepin—CHRM2—Diphenhydramine—atopic dermatitis	0.0123	0.0536	CbGbCtD
Doxepin—Imipramine—Diphenhydramine—atopic dermatitis	0.0121	0.0473	CrCrCtD
Doxepin—HRH1—Loratadine—atopic dermatitis	0.0113	0.0489	CbGbCtD
Doxepin—HRH1—Diphenhydramine—atopic dermatitis	0.0113	0.0489	CbGbCtD
Doxepin—Promethazine—Diphenhydramine—atopic dermatitis	0.0112	0.0438	CrCrCtD
Doxepin—Alimemazine—Diphenhydramine—atopic dermatitis	0.011	0.043	CrCrCtD
Doxepin—Clofedanol—Diphenhydramine—atopic dermatitis	0.0103	0.0401	CrCrCtD
Doxepin—Orphenadrine—Diphenhydramine—atopic dermatitis	0.00993	0.0388	CrCrCtD
Doxepin—Promazine—Diphenhydramine—atopic dermatitis	0.00948	0.037	CrCrCtD
Doxepin—CYP3A4—Pimecrolimus—atopic dermatitis	0.00658	0.0285	CbGbCtD
Doxepin—ABCB1—Tacrolimus—atopic dermatitis	0.00653	0.0283	CbGbCtD
Doxepin—CYP2C19—Loratadine—atopic dermatitis	0.00592	0.0257	CbGbCtD
Doxepin—CYP2C19—Diphenhydramine—atopic dermatitis	0.00592	0.0257	CbGbCtD
Doxepin—CYP1A2—Diphenhydramine—atopic dermatitis	0.00546	0.0237	CbGbCtD
Doxepin—CYP2C9—Loratadine—atopic dermatitis	0.00492	0.0214	CbGbCtD
Doxepin—CYP2C9—Diphenhydramine—atopic dermatitis	0.00492	0.0214	CbGbCtD
Doxepin—ABCB1—Loratadine—atopic dermatitis	0.00478	0.0207	CbGbCtD
Doxepin—CYP2D6—Loratadine—atopic dermatitis	0.0045	0.0195	CbGbCtD
Doxepin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0045	0.0195	CbGbCtD
Doxepin—ABCB1—Methylprednisolone—atopic dermatitis	0.00437	0.019	CbGbCtD
Doxepin—CYP3A4—Tacrolimus—atopic dermatitis	0.00391	0.017	CbGbCtD
Doxepin—CYP2C19—Prednisone—atopic dermatitis	0.00328	0.0142	CbGbCtD
Doxepin—CYP3A4—Loratadine—atopic dermatitis	0.00286	0.0124	CbGbCtD
Doxepin—ABCB1—Betamethasone—atopic dermatitis	0.00284	0.0123	CbGbCtD
Doxepin—ABCB1—Prednisolone—atopic dermatitis	0.0028	0.0122	CbGbCtD
Doxepin—ABCB1—Hydrocortisone—atopic dermatitis	0.00266	0.0115	CbGbCtD
Doxepin—ABCB1—Prednisone—atopic dermatitis	0.00265	0.0115	CbGbCtD
Doxepin—CYP3A4—Methylprednisolone—atopic dermatitis	0.00262	0.0114	CbGbCtD
Doxepin—CYP2C19—Dexamethasone—atopic dermatitis	0.00205	0.00889	CbGbCtD
Doxepin—CYP3A4—Triamcinolone—atopic dermatitis	0.00198	0.00861	CbGbCtD
Doxepin—CYP2C9—Dexamethasone—atopic dermatitis	0.0017	0.00739	CbGbCtD
Doxepin—CYP3A4—Betamethasone—atopic dermatitis	0.0017	0.00738	CbGbCtD
Doxepin—CYP3A4—Prednisolone—atopic dermatitis	0.00168	0.00729	CbGbCtD
Doxepin—ABCB1—Dexamethasone—atopic dermatitis	0.00165	0.00717	CbGbCtD
Doxepin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00159	0.00691	CbGbCtD
Doxepin—CYP3A4—Prednisone—atopic dermatitis	0.00159	0.00688	CbGbCtD
Doxepin—CYP2D6—Dexamethasone—atopic dermatitis	0.00156	0.00676	CbGbCtD
Doxepin—CYP3A4—Dexamethasone—atopic dermatitis	0.00099	0.0043	CbGbCtD
Doxepin—CHRM5—skin epidermis—atopic dermatitis	0.000141	0.201	CbGeAlD
Doxepin—HRH2—skin of body—atopic dermatitis	4.58e-05	0.0651	CbGeAlD
Doxepin—CHRM5—skin of body—atopic dermatitis	4.37e-05	0.0622	CbGeAlD
Doxepin—CHRM4—head—atopic dermatitis	3.65e-05	0.0519	CbGeAlD
Doxepin—HTR6—head—atopic dermatitis	3.27e-05	0.0465	CbGeAlD
Doxepin—HRH2—head—atopic dermatitis	2.99e-05	0.0425	CbGeAlD
Doxepin—Rash—Tacrolimus—atopic dermatitis	2.95e-05	0.000338	CcSEcCtD
Doxepin—Dermatitis—Tacrolimus—atopic dermatitis	2.95e-05	0.000338	CcSEcCtD
Doxepin—Shock—Prednisolone—atopic dermatitis	2.94e-05	0.000337	CcSEcCtD
Doxepin—Cough—Triamcinolone—atopic dermatitis	2.94e-05	0.000337	CcSEcCtD
Doxepin—Headache—Tacrolimus—atopic dermatitis	2.93e-05	0.000336	CcSEcCtD
Doxepin—Oedema—Hydrocortisone—atopic dermatitis	2.92e-05	0.000335	CcSEcCtD
Doxepin—Convulsion—Triamcinolone—atopic dermatitis	2.92e-05	0.000335	CcSEcCtD
Doxepin—Tachycardia—Prednisolone—atopic dermatitis	2.92e-05	0.000335	CcSEcCtD
Doxepin—Convulsion—Methylprednisolone—atopic dermatitis	2.91e-05	0.000334	CcSEcCtD
Doxepin—Hypertension—Triamcinolone—atopic dermatitis	2.91e-05	0.000333	CcSEcCtD
Doxepin—Hypertension—Methylprednisolone—atopic dermatitis	2.9e-05	0.000333	CcSEcCtD
Doxepin—Infection—Hydrocortisone—atopic dermatitis	2.9e-05	0.000333	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisolone—atopic dermatitis	2.89e-05	0.000331	CcSEcCtD
Doxepin—Shock—Hydrocortisone—atopic dermatitis	2.87e-05	0.000329	CcSEcCtD
Doxepin—Myalgia—Triamcinolone—atopic dermatitis	2.87e-05	0.000329	CcSEcCtD
Doxepin—Nervous system disorder—Hydrocortisone—atopic dermatitis	2.86e-05	0.000328	CcSEcCtD
Doxepin—Arthralgia—Methylprednisolone—atopic dermatitis	2.86e-05	0.000328	CcSEcCtD
Doxepin—Myalgia—Methylprednisolone—atopic dermatitis	2.86e-05	0.000328	CcSEcCtD
Doxepin—Eye disorder—Prednisone—atopic dermatitis	2.86e-05	0.000328	CcSEcCtD
Doxepin—CHRM5—head—atopic dermatitis	2.85e-05	0.0406	CbGeAlD
Doxepin—Anxiety—Methylprednisolone—atopic dermatitis	2.85e-05	0.000327	CcSEcCtD
Doxepin—Tachycardia—Hydrocortisone—atopic dermatitis	2.85e-05	0.000327	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	2.84e-05	0.000326	CcSEcCtD
Doxepin—Flushing—Prednisone—atopic dermatitis	2.84e-05	0.000325	CcSEcCtD
Doxepin—Skin disorder—Hydrocortisone—atopic dermatitis	2.84e-05	0.000325	CcSEcCtD
Doxepin—Ill-defined disorder—Betamethasone—atopic dermatitis	2.84e-05	0.000325	CcSEcCtD
Doxepin—Ill-defined disorder—Dexamethasone—atopic dermatitis	2.84e-05	0.000325	CcSEcCtD
Doxepin—Discomfort—Triamcinolone—atopic dermatitis	2.83e-05	0.000325	CcSEcCtD
Doxepin—Discomfort—Methylprednisolone—atopic dermatitis	2.83e-05	0.000324	CcSEcCtD
Doxepin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	2.82e-05	0.000324	CcSEcCtD
Doxepin—Dry mouth—Triamcinolone—atopic dermatitis	2.8e-05	0.000322	CcSEcCtD
Doxepin—Anorexia—Hydrocortisone—atopic dermatitis	2.78e-05	0.000319	CcSEcCtD
Doxepin—Nausea—Tacrolimus—atopic dermatitis	2.78e-05	0.000319	CcSEcCtD
Doxepin—Angiopathy—Prednisone—atopic dermatitis	2.77e-05	0.000318	CcSEcCtD
Doxepin—Confusional state—Methylprednisolone—atopic dermatitis	2.77e-05	0.000317	CcSEcCtD
Doxepin—Immune system disorder—Prednisone—atopic dermatitis	2.76e-05	0.000317	CcSEcCtD
Doxepin—Malaise—Dexamethasone—atopic dermatitis	2.76e-05	0.000316	CcSEcCtD
Doxepin—Malaise—Betamethasone—atopic dermatitis	2.76e-05	0.000316	CcSEcCtD
Doxepin—Oedema—Triamcinolone—atopic dermatitis	2.75e-05	0.000315	CcSEcCtD
Doxepin—Vertigo—Dexamethasone—atopic dermatitis	2.75e-05	0.000315	CcSEcCtD
Doxepin—Vertigo—Betamethasone—atopic dermatitis	2.75e-05	0.000315	CcSEcCtD
Doxepin—Syncope—Betamethasone—atopic dermatitis	2.74e-05	0.000314	CcSEcCtD
Doxepin—Syncope—Dexamethasone—atopic dermatitis	2.74e-05	0.000314	CcSEcCtD
Doxepin—Arrhythmia—Prednisone—atopic dermatitis	2.73e-05	0.000313	CcSEcCtD
Doxepin—Infection—Triamcinolone—atopic dermatitis	2.73e-05	0.000313	CcSEcCtD
Doxepin—Hypotension—Hydrocortisone—atopic dermatitis	2.73e-05	0.000313	CcSEcCtD
Doxepin—Infection—Methylprednisolone—atopic dermatitis	2.72e-05	0.000312	CcSEcCtD
Doxepin—HTR2B—skin of body—atopic dermatitis	2.72e-05	0.0387	CbGeAlD
Doxepin—Shock—Triamcinolone—atopic dermatitis	2.7e-05	0.00031	CcSEcCtD
Doxepin—Insomnia—Prednisolone—atopic dermatitis	2.7e-05	0.00031	CcSEcCtD
Doxepin—Alopecia—Prednisone—atopic dermatitis	2.7e-05	0.00031	CcSEcCtD
Doxepin—Shock—Methylprednisolone—atopic dermatitis	2.7e-05	0.000309	CcSEcCtD
Doxepin—Nervous system disorder—Methylprednisolone—atopic dermatitis	2.69e-05	0.000308	CcSEcCtD
Doxepin—Loss of consciousness—Betamethasone—atopic dermatitis	2.69e-05	0.000308	CcSEcCtD
Doxepin—Loss of consciousness—Dexamethasone—atopic dermatitis	2.69e-05	0.000308	CcSEcCtD
Doxepin—Paraesthesia—Prednisolone—atopic dermatitis	2.68e-05	0.000308	CcSEcCtD
Doxepin—Tachycardia—Triamcinolone—atopic dermatitis	2.68e-05	0.000308	CcSEcCtD
Doxepin—Mental disorder—Prednisone—atopic dermatitis	2.68e-05	0.000307	CcSEcCtD
Doxepin—Tachycardia—Methylprednisolone—atopic dermatitis	2.68e-05	0.000307	CcSEcCtD
Doxepin—Skin disorder—Methylprednisolone—atopic dermatitis	2.66e-05	0.000305	CcSEcCtD
Doxepin—Erythema—Prednisone—atopic dermatitis	2.66e-05	0.000305	CcSEcCtD
Doxepin—Malnutrition—Prednisone—atopic dermatitis	2.66e-05	0.000305	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	2.66e-05	0.000305	CcSEcCtD
Doxepin—Hyperhidrosis—Triamcinolone—atopic dermatitis	2.66e-05	0.000305	CcSEcCtD
Doxepin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	2.65e-05	0.000304	CcSEcCtD
Doxepin—Convulsion—Dexamethasone—atopic dermatitis	2.65e-05	0.000304	CcSEcCtD
Doxepin—Convulsion—Betamethasone—atopic dermatitis	2.65e-05	0.000304	CcSEcCtD
Doxepin—Insomnia—Hydrocortisone—atopic dermatitis	2.64e-05	0.000303	CcSEcCtD
Doxepin—Hypertension—Betamethasone—atopic dermatitis	2.64e-05	0.000303	CcSEcCtD
Doxepin—Hypertension—Dexamethasone—atopic dermatitis	2.64e-05	0.000303	CcSEcCtD
Doxepin—Paraesthesia—Hydrocortisone—atopic dermatitis	2.62e-05	0.000301	CcSEcCtD
Doxepin—ADRA1B—head—atopic dermatitis	2.61e-05	0.0371	CbGeAlD
Doxepin—Myalgia—Dexamethasone—atopic dermatitis	2.6e-05	0.000298	CcSEcCtD
Doxepin—Myalgia—Betamethasone—atopic dermatitis	2.6e-05	0.000298	CcSEcCtD
Doxepin—Anxiety—Dexamethasone—atopic dermatitis	2.59e-05	0.000297	CcSEcCtD
Doxepin—Anxiety—Betamethasone—atopic dermatitis	2.59e-05	0.000297	CcSEcCtD
Doxepin—Discomfort—Dexamethasone—atopic dermatitis	2.57e-05	0.000295	CcSEcCtD
Doxepin—Discomfort—Betamethasone—atopic dermatitis	2.57e-05	0.000295	CcSEcCtD
Doxepin—Dyspepsia—Hydrocortisone—atopic dermatitis	2.57e-05	0.000295	CcSEcCtD
Doxepin—Hypotension—Methylprednisolone—atopic dermatitis	2.56e-05	0.000294	CcSEcCtD
Doxepin—Pain—Prednisolone—atopic dermatitis	2.56e-05	0.000293	CcSEcCtD
Doxepin—ADRA1D—head—atopic dermatitis	2.55e-05	0.0363	CbGeAlD
Doxepin—Decreased appetite—Hydrocortisone—atopic dermatitis	2.54e-05	0.000291	CcSEcCtD
Doxepin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	2.52e-05	0.000289	CcSEcCtD
Doxepin—Fatigue—Hydrocortisone—atopic dermatitis	2.52e-05	0.000289	CcSEcCtD
Doxepin—Vision blurred—Prednisone—atopic dermatitis	2.51e-05	0.000288	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	2.5e-05	0.000287	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	2.5e-05	0.000287	CcSEcCtD
Doxepin—Pain—Hydrocortisone—atopic dermatitis	2.5e-05	0.000286	CcSEcCtD
Doxepin—Oedema—Betamethasone—atopic dermatitis	2.49e-05	0.000286	CcSEcCtD
Doxepin—Oedema—Dexamethasone—atopic dermatitis	2.49e-05	0.000286	CcSEcCtD
Doxepin—Insomnia—Triamcinolone—atopic dermatitis	2.49e-05	0.000285	CcSEcCtD
Doxepin—Insomnia—Methylprednisolone—atopic dermatitis	2.48e-05	0.000284	CcSEcCtD
Doxepin—Infection—Dexamethasone—atopic dermatitis	2.48e-05	0.000284	CcSEcCtD
Doxepin—Infection—Betamethasone—atopic dermatitis	2.48e-05	0.000284	CcSEcCtD
Doxepin—Ill-defined disorder—Prednisone—atopic dermatitis	2.47e-05	0.000283	CcSEcCtD
Doxepin—Paraesthesia—Triamcinolone—atopic dermatitis	2.47e-05	0.000283	CcSEcCtD
Doxepin—Feeling abnormal—Prednisolone—atopic dermatitis	2.46e-05	0.000282	CcSEcCtD
Doxepin—Paraesthesia—Methylprednisolone—atopic dermatitis	2.46e-05	0.000282	CcSEcCtD
Doxepin—Anaemia—Prednisone—atopic dermatitis	2.46e-05	0.000282	CcSEcCtD
Doxepin—Shock—Dexamethasone—atopic dermatitis	2.45e-05	0.000281	CcSEcCtD
Doxepin—Shock—Betamethasone—atopic dermatitis	2.45e-05	0.000281	CcSEcCtD
Doxepin—Dyspnoea—Triamcinolone—atopic dermatitis	2.45e-05	0.000281	CcSEcCtD
Doxepin—Nervous system disorder—Betamethasone—atopic dermatitis	2.45e-05	0.00028	CcSEcCtD
Doxepin—Nervous system disorder—Dexamethasone—atopic dermatitis	2.45e-05	0.00028	CcSEcCtD
Doxepin—Agitation—Prednisone—atopic dermatitis	2.45e-05	0.00028	CcSEcCtD
Doxepin—Thrombocytopenia—Betamethasone—atopic dermatitis	2.44e-05	0.00028	CcSEcCtD
Doxepin—Thrombocytopenia—Dexamethasone—atopic dermatitis	2.44e-05	0.00028	CcSEcCtD
Doxepin—Tachycardia—Dexamethasone—atopic dermatitis	2.43e-05	0.000279	CcSEcCtD
Doxepin—Tachycardia—Betamethasone—atopic dermatitis	2.43e-05	0.000279	CcSEcCtD
Doxepin—Dyspepsia—Triamcinolone—atopic dermatitis	2.42e-05	0.000277	CcSEcCtD
Doxepin—Dyspepsia—Methylprednisolone—atopic dermatitis	2.41e-05	0.000277	CcSEcCtD
Doxepin—Hyperhidrosis—Dexamethasone—atopic dermatitis	2.41e-05	0.000276	CcSEcCtD
Doxepin—Hyperhidrosis—Betamethasone—atopic dermatitis	2.41e-05	0.000276	CcSEcCtD
Doxepin—Feeling abnormal—Hydrocortisone—atopic dermatitis	2.41e-05	0.000276	CcSEcCtD
Doxepin—Malaise—Prednisone—atopic dermatitis	2.4e-05	0.000275	CcSEcCtD
Doxepin—Vertigo—Prednisone—atopic dermatitis	2.39e-05	0.000274	CcSEcCtD
Doxepin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	2.39e-05	0.000274	CcSEcCtD
Doxepin—Syncope—Prednisone—atopic dermatitis	2.39e-05	0.000274	CcSEcCtD
Doxepin—Anorexia—Betamethasone—atopic dermatitis	2.38e-05	0.000273	CcSEcCtD
Doxepin—Anorexia—Dexamethasone—atopic dermatitis	2.38e-05	0.000273	CcSEcCtD
Doxepin—Urticaria—Prednisolone—atopic dermatitis	2.37e-05	0.000272	CcSEcCtD
Doxepin—Fatigue—Triamcinolone—atopic dermatitis	2.37e-05	0.000272	CcSEcCtD
Doxepin—Fatigue—Methylprednisolone—atopic dermatitis	2.36e-05	0.000271	CcSEcCtD
Doxepin—Pain—Triamcinolone—atopic dermatitis	2.35e-05	0.00027	CcSEcCtD
Doxepin—Loss of consciousness—Prednisone—atopic dermatitis	2.34e-05	0.000268	CcSEcCtD
Doxepin—Hypotension—Betamethasone—atopic dermatitis	2.33e-05	0.000267	CcSEcCtD
Doxepin—Hypotension—Dexamethasone—atopic dermatitis	2.33e-05	0.000267	CcSEcCtD
Doxepin—Urticaria—Hydrocortisone—atopic dermatitis	2.32e-05	0.000266	CcSEcCtD
Doxepin—Body temperature increased—Hydrocortisone—atopic dermatitis	2.31e-05	0.000265	CcSEcCtD
Doxepin—Abdominal pain—Hydrocortisone—atopic dermatitis	2.31e-05	0.000265	CcSEcCtD
Doxepin—Convulsion—Prednisone—atopic dermatitis	2.31e-05	0.000264	CcSEcCtD
Doxepin—Hypertension—Prednisone—atopic dermatitis	2.3e-05	0.000263	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	2.27e-05	0.000261	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	2.27e-05	0.000261	CcSEcCtD
Doxepin—Myalgia—Prednisone—atopic dermatitis	2.27e-05	0.00026	CcSEcCtD
Doxepin—Arthralgia—Prednisone—atopic dermatitis	2.27e-05	0.00026	CcSEcCtD
Doxepin—Feeling abnormal—Triamcinolone—atopic dermatitis	2.27e-05	0.00026	CcSEcCtD
Doxepin—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.26e-05	0.000259	CcSEcCtD
Doxepin—Anxiety—Prednisone—atopic dermatitis	2.26e-05	0.000259	CcSEcCtD
Doxepin—Insomnia—Dexamethasone—atopic dermatitis	2.26e-05	0.000259	CcSEcCtD
Doxepin—Insomnia—Betamethasone—atopic dermatitis	2.26e-05	0.000259	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.25e-05	0.000258	CcSEcCtD
Doxepin—HTR2A—neck—atopic dermatitis	2.24e-05	0.0319	CbGeAlD
Doxepin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.24e-05	0.000257	CcSEcCtD
Doxepin—Paraesthesia—Betamethasone—atopic dermatitis	2.24e-05	0.000257	CcSEcCtD
Doxepin—Paraesthesia—Dexamethasone—atopic dermatitis	2.24e-05	0.000257	CcSEcCtD
Doxepin—Discomfort—Prednisone—atopic dermatitis	2.24e-05	0.000257	CcSEcCtD
Doxepin—Hypersensitivity—Prednisolone—atopic dermatitis	2.2e-05	0.000253	CcSEcCtD
Doxepin—Dyspepsia—Betamethasone—atopic dermatitis	2.2e-05	0.000252	CcSEcCtD
Doxepin—Dyspepsia—Dexamethasone—atopic dermatitis	2.2e-05	0.000252	CcSEcCtD
Doxepin—Urticaria—Triamcinolone—atopic dermatitis	2.18e-05	0.00025	CcSEcCtD
Doxepin—Urticaria—Methylprednisolone—atopic dermatitis	2.18e-05	0.00025	CcSEcCtD
Doxepin—Body temperature increased—Triamcinolone—atopic dermatitis	2.17e-05	0.000249	CcSEcCtD
Doxepin—Oedema—Prednisone—atopic dermatitis	2.17e-05	0.000249	CcSEcCtD
Doxepin—Abdominal pain—Methylprednisolone—atopic dermatitis	2.17e-05	0.000249	CcSEcCtD
Doxepin—Decreased appetite—Betamethasone—atopic dermatitis	2.17e-05	0.000249	CcSEcCtD
Doxepin—Decreased appetite—Dexamethasone—atopic dermatitis	2.17e-05	0.000249	CcSEcCtD
Doxepin—Infection—Prednisone—atopic dermatitis	2.16e-05	0.000247	CcSEcCtD
Doxepin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.15e-05	0.000247	CcSEcCtD
Doxepin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.15e-05	0.000247	CcSEcCtD
Doxepin—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.15e-05	0.000247	CcSEcCtD
Doxepin—Fatigue—Betamethasone—atopic dermatitis	2.15e-05	0.000247	CcSEcCtD
Doxepin—Fatigue—Dexamethasone—atopic dermatitis	2.15e-05	0.000247	CcSEcCtD
Doxepin—Shock—Prednisone—atopic dermatitis	2.14e-05	0.000245	CcSEcCtD
Doxepin—Pain—Betamethasone—atopic dermatitis	2.13e-05	0.000245	CcSEcCtD
Doxepin—Pain—Dexamethasone—atopic dermatitis	2.13e-05	0.000245	CcSEcCtD
Doxepin—Nervous system disorder—Prednisone—atopic dermatitis	2.13e-05	0.000244	CcSEcCtD
Doxepin—Tachycardia—Prednisone—atopic dermatitis	2.12e-05	0.000243	CcSEcCtD
Doxepin—Skin disorder—Prednisone—atopic dermatitis	2.11e-05	0.000242	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisone—atopic dermatitis	2.1e-05	0.000241	CcSEcCtD
Doxepin—Asthenia—Hydrocortisone—atopic dermatitis	2.09e-05	0.00024	CcSEcCtD
Doxepin—Anorexia—Prednisone—atopic dermatitis	2.07e-05	0.000237	CcSEcCtD
Doxepin—Pruritus—Hydrocortisone—atopic dermatitis	2.07e-05	0.000237	CcSEcCtD
Doxepin—Feeling abnormal—Dexamethasone—atopic dermatitis	2.06e-05	0.000236	CcSEcCtD
Doxepin—Feeling abnormal—Betamethasone—atopic dermatitis	2.06e-05	0.000236	CcSEcCtD
Doxepin—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.04e-05	0.000234	CcSEcCtD
Doxepin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.04e-05	0.000234	CcSEcCtD
Doxepin—Hypersensitivity—Triamcinolone—atopic dermatitis	2.03e-05	0.000232	CcSEcCtD
Doxepin—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.02e-05	0.000232	CcSEcCtD
Doxepin—Diarrhoea—Hydrocortisone—atopic dermatitis	2e-05	0.000229	CcSEcCtD
Doxepin—Urticaria—Dexamethasone—atopic dermatitis	1.98e-05	0.000227	CcSEcCtD
Doxepin—Urticaria—Betamethasone—atopic dermatitis	1.98e-05	0.000227	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.98e-05	0.000227	CcSEcCtD
Doxepin—Dizziness—Prednisolone—atopic dermatitis	1.98e-05	0.000227	CcSEcCtD
Doxepin—Asthenia—Triamcinolone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Abdominal pain—Betamethasone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Body temperature increased—Dexamethasone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Body temperature increased—Betamethasone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Abdominal pain—Dexamethasone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Asthenia—Methylprednisolone—atopic dermatitis	1.97e-05	0.000226	CcSEcCtD
Doxepin—Insomnia—Prednisone—atopic dermatitis	1.96e-05	0.000225	CcSEcCtD
Doxepin—CHRM2—head—atopic dermatitis	1.96e-05	0.0279	CbGeAlD
Doxepin—Paraesthesia—Prednisone—atopic dermatitis	1.95e-05	0.000224	CcSEcCtD
Doxepin—Pruritus—Triamcinolone—atopic dermatitis	1.94e-05	0.000223	CcSEcCtD
Doxepin—Pruritus—Methylprednisolone—atopic dermatitis	1.94e-05	0.000223	CcSEcCtD
Doxepin—Dizziness—Hydrocortisone—atopic dermatitis	1.93e-05	0.000221	CcSEcCtD
Doxepin—Dyspepsia—Prednisone—atopic dermatitis	1.91e-05	0.000219	CcSEcCtD
Doxepin—Decreased appetite—Prednisone—atopic dermatitis	1.89e-05	0.000217	CcSEcCtD
Doxepin—HTR2C—head—atopic dermatitis	1.89e-05	0.0269	CbGeAlD
Doxepin—Rash—Prednisolone—atopic dermatitis	1.88e-05	0.000216	CcSEcCtD
Doxepin—Dermatitis—Prednisolone—atopic dermatitis	1.88e-05	0.000216	CcSEcCtD
Doxepin—Diarrhoea—Methylprednisolone—atopic dermatitis	1.88e-05	0.000215	CcSEcCtD
Doxepin—Fatigue—Prednisone—atopic dermatitis	1.87e-05	0.000215	CcSEcCtD
Doxepin—Headache—Prednisolone—atopic dermatitis	1.87e-05	0.000215	CcSEcCtD
Doxepin—Constipation—Prednisone—atopic dermatitis	1.86e-05	0.000213	CcSEcCtD
Doxepin—Vomiting—Hydrocortisone—atopic dermatitis	1.86e-05	0.000213	CcSEcCtD
Doxepin—Rash—Hydrocortisone—atopic dermatitis	1.84e-05	0.000211	CcSEcCtD
Doxepin—Dermatitis—Hydrocortisone—atopic dermatitis	1.84e-05	0.000211	CcSEcCtD
Doxepin—Headache—Hydrocortisone—atopic dermatitis	1.83e-05	0.00021	CcSEcCtD
Doxepin—Dizziness—Triamcinolone—atopic dermatitis	1.82e-05	0.000208	CcSEcCtD
Doxepin—Dizziness—Methylprednisolone—atopic dermatitis	1.81e-05	0.000208	CcSEcCtD
Doxepin—Feeling abnormal—Prednisone—atopic dermatitis	1.79e-05	0.000205	CcSEcCtD
Doxepin—SLC6A4—head—atopic dermatitis	1.79e-05	0.0255	CbGeAlD
Doxepin—Asthenia—Dexamethasone—atopic dermatitis	1.79e-05	0.000205	CcSEcCtD
Doxepin—Asthenia—Betamethasone—atopic dermatitis	1.79e-05	0.000205	CcSEcCtD
Doxepin—CHRM1—head—atopic dermatitis	1.78e-05	0.0254	CbGeAlD
Doxepin—Gastrointestinal pain—Prednisone—atopic dermatitis	1.78e-05	0.000204	CcSEcCtD
Doxepin—Nausea—Prednisolone—atopic dermatitis	1.78e-05	0.000204	CcSEcCtD
Doxepin—HTR2B—head—atopic dermatitis	1.77e-05	0.0252	CbGeAlD
Doxepin—Pruritus—Dexamethasone—atopic dermatitis	1.76e-05	0.000202	CcSEcCtD
Doxepin—Pruritus—Betamethasone—atopic dermatitis	1.76e-05	0.000202	CcSEcCtD
Doxepin—Vomiting—Triamcinolone—atopic dermatitis	1.75e-05	0.0002	CcSEcCtD
Doxepin—Vomiting—Methylprednisolone—atopic dermatitis	1.74e-05	0.0002	CcSEcCtD
Doxepin—Nausea—Hydrocortisone—atopic dermatitis	1.73e-05	0.000199	CcSEcCtD
Doxepin—Rash—Triamcinolone—atopic dermatitis	1.73e-05	0.000199	CcSEcCtD
Doxepin—Dermatitis—Triamcinolone—atopic dermatitis	1.73e-05	0.000199	CcSEcCtD
Doxepin—Rash—Methylprednisolone—atopic dermatitis	1.73e-05	0.000198	CcSEcCtD
Doxepin—Dermatitis—Methylprednisolone—atopic dermatitis	1.73e-05	0.000198	CcSEcCtD
Doxepin—Urticaria—Prednisone—atopic dermatitis	1.73e-05	0.000198	CcSEcCtD
Doxepin—Headache—Triamcinolone—atopic dermatitis	1.72e-05	0.000197	CcSEcCtD
Doxepin—Headache—Methylprednisolone—atopic dermatitis	1.72e-05	0.000197	CcSEcCtD
Doxepin—Abdominal pain—Prednisone—atopic dermatitis	1.72e-05	0.000197	CcSEcCtD
Doxepin—Body temperature increased—Prednisone—atopic dermatitis	1.72e-05	0.000197	CcSEcCtD
Doxepin—Diarrhoea—Dexamethasone—atopic dermatitis	1.71e-05	0.000196	CcSEcCtD
Doxepin—Diarrhoea—Betamethasone—atopic dermatitis	1.71e-05	0.000196	CcSEcCtD
Doxepin—Dizziness—Dexamethasone—atopic dermatitis	1.65e-05	0.000189	CcSEcCtD
Doxepin—Dizziness—Betamethasone—atopic dermatitis	1.65e-05	0.000189	CcSEcCtD
Doxepin—Nausea—Triamcinolone—atopic dermatitis	1.63e-05	0.000187	CcSEcCtD
Doxepin—Nausea—Methylprednisolone—atopic dermatitis	1.63e-05	0.000187	CcSEcCtD
Doxepin—Hypersensitivity—Prednisone—atopic dermatitis	1.6e-05	0.000184	CcSEcCtD
Doxepin—CHRM3—head—atopic dermatitis	1.6e-05	0.0227	CbGeAlD
Doxepin—HTR1A—head—atopic dermatitis	1.59e-05	0.0226	CbGeAlD
Doxepin—Vomiting—Dexamethasone—atopic dermatitis	1.59e-05	0.000182	CcSEcCtD
Doxepin—Vomiting—Betamethasone—atopic dermatitis	1.59e-05	0.000182	CcSEcCtD
Doxepin—SLC6A2—head—atopic dermatitis	1.58e-05	0.0224	CbGeAlD
Doxepin—Rash—Dexamethasone—atopic dermatitis	1.57e-05	0.00018	CcSEcCtD
Doxepin—Rash—Betamethasone—atopic dermatitis	1.57e-05	0.00018	CcSEcCtD
Doxepin—Dermatitis—Betamethasone—atopic dermatitis	1.57e-05	0.00018	CcSEcCtD
Doxepin—Dermatitis—Dexamethasone—atopic dermatitis	1.57e-05	0.00018	CcSEcCtD
Doxepin—Headache—Betamethasone—atopic dermatitis	1.56e-05	0.000179	CcSEcCtD
Doxepin—Headache—Dexamethasone—atopic dermatitis	1.56e-05	0.000179	CcSEcCtD
Doxepin—Asthenia—Prednisone—atopic dermatitis	1.56e-05	0.000179	CcSEcCtD
Doxepin—Pruritus—Prednisone—atopic dermatitis	1.54e-05	0.000176	CcSEcCtD
Doxepin—Diarrhoea—Prednisone—atopic dermatitis	1.49e-05	0.00017	CcSEcCtD
Doxepin—Nausea—Betamethasone—atopic dermatitis	1.48e-05	0.00017	CcSEcCtD
Doxepin—Nausea—Dexamethasone—atopic dermatitis	1.48e-05	0.00017	CcSEcCtD
Doxepin—ADRA1A—head—atopic dermatitis	1.47e-05	0.0208	CbGeAlD
Doxepin—Dizziness—Prednisone—atopic dermatitis	1.44e-05	0.000165	CcSEcCtD
Doxepin—DRD2—head—atopic dermatitis	1.44e-05	0.0204	CbGeAlD
Doxepin—KCNH2—head—atopic dermatitis	1.41e-05	0.0201	CbGeAlD
Doxepin—ADRA2C—head—atopic dermatitis	1.4e-05	0.0199	CbGeAlD
Doxepin—Vomiting—Prednisone—atopic dermatitis	1.38e-05	0.000158	CcSEcCtD
Doxepin—Rash—Prednisone—atopic dermatitis	1.37e-05	0.000157	CcSEcCtD
Doxepin—Dermatitis—Prednisone—atopic dermatitis	1.37e-05	0.000157	CcSEcCtD
Doxepin—Headache—Prednisone—atopic dermatitis	1.36e-05	0.000156	CcSEcCtD
Doxepin—Nausea—Prednisone—atopic dermatitis	1.29e-05	0.000148	CcSEcCtD
Doxepin—HRH1—head—atopic dermatitis	1.13e-05	0.0161	CbGeAlD
Doxepin—ADRA2A—head—atopic dermatitis	1.11e-05	0.0158	CbGeAlD
Doxepin—HTR2A—head—atopic dermatitis	9.47e-06	0.0135	CbGeAlD
Doxepin—CYP2D6—head—atopic dermatitis	8.63e-06	0.0123	CbGeAlD
Doxepin—ABCB1—head—atopic dermatitis	6.21e-06	0.00883	CbGeAlD
Doxepin—CHRM2—Signaling Pathways—IL5—atopic dermatitis	4.12e-06	0.000143	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	4.11e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	4.1e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	4.1e-06	0.000142	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	4.09e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	4.09e-06	0.000142	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NGF—atopic dermatitis	4.07e-06	0.000141	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	4.05e-06	0.00014	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NGF—atopic dermatitis	4.03e-06	0.00014	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	4.03e-06	0.00014	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	4.01e-06	0.000139	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	4.01e-06	0.000139	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	4e-06	0.000139	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	3.97e-06	0.000138	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	3.96e-06	0.000137	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	3.94e-06	0.000137	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	3.92e-06	0.000136	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—MAPK8—atopic dermatitis	3.88e-06	0.000134	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	3.87e-06	0.000134	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	3.83e-06	0.000133	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	3.82e-06	0.000132	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.8e-06	0.000132	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	3.79e-06	0.000131	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	3.77e-06	0.000131	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.75e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	3.69e-06	0.000128	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	3.68e-06	0.000128	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	3.68e-06	0.000127	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.64e-06	0.000126	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	3.63e-06	0.000126	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.62e-06	0.000125	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	3.6e-06	0.000125	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.6e-06	0.000125	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.59e-06	0.000124	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	3.58e-06	0.000124	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	3.58e-06	0.000124	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	3.57e-06	0.000124	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	3.56e-06	0.000124	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PPARA—atopic dermatitis	3.56e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	3.56e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	3.55e-06	0.000123	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	3.54e-06	0.000123	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	3.51e-06	0.000122	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	3.5e-06	0.000121	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.5e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	3.47e-06	0.00012	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	3.46e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	3.45e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.45e-06	0.000119	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	3.44e-06	0.000119	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CXCL8—atopic dermatitis	3.42e-06	0.000118	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	3.42e-06	0.000118	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	3.4e-06	0.000118	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	3.39e-06	0.000118	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.36e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	3.35e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	3.33e-06	0.000115	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	3.32e-06	0.000115	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NGF—atopic dermatitis	3.3e-06	0.000114	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	3.29e-06	0.000114	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.29e-06	0.000114	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NGF—atopic dermatitis	3.28e-06	0.000114	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	3.27e-06	0.000113	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL2—atopic dermatitis	3.27e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	3.25e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	3.25e-06	0.000113	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—IL6—atopic dermatitis	3.25e-06	0.000113	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	3.21e-06	0.000111	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	3.19e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	3.19e-06	0.000111	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	3.18e-06	0.00011	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	3.18e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PPARA—atopic dermatitis	3.15e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	3.14e-06	0.000109	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	3.14e-06	0.000109	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	3.13e-06	0.000108	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL5—atopic dermatitis	3.13e-06	0.000108	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.13e-06	0.000108	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	3.12e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	3.12e-06	0.000108	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.12e-06	0.000108	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.11e-06	0.000108	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	3.11e-06	0.000108	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	3.1e-06	0.000107	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	3.08e-06	0.000107	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL5—atopic dermatitis	3.07e-06	0.000106	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	3.07e-06	0.000106	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	3.06e-06	0.000106	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.06e-06	0.000106	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	3.06e-06	0.000106	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	3.05e-06	0.000106	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	3.04e-06	0.000105	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	3.04e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	3.02e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	3.01e-06	0.000104	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MAPK8—atopic dermatitis	3.01e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	2.99e-06	0.000104	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	2.99e-06	0.000104	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	2.98e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.97e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	2.96e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	2.93e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	2.92e-06	0.000101	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NGF—atopic dermatitis	2.9e-06	0.0001	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PPARA—atopic dermatitis	2.89e-06	0.0001	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	2.88e-06	0.0001	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NGF—atopic dermatitis	2.85e-06	9.88e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NGF—atopic dermatitis	2.84e-06	9.86e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.84e-06	9.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.84e-06	9.84e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NGF—atopic dermatitis	2.84e-06	9.83e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	2.83e-06	9.82e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NGF—atopic dermatitis	2.83e-06	9.8e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.82e-06	9.79e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	2.82e-06	9.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCR5—atopic dermatitis	2.82e-06	9.77e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	2.81e-06	9.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	2.8e-06	9.71e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NGF—atopic dermatitis	2.8e-06	9.7e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	2.79e-06	9.68e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	2.79e-06	9.66e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	2.78e-06	9.63e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	2.77e-06	9.61e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCR5—atopic dermatitis	2.77e-06	9.59e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	2.76e-06	9.56e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL2—atopic dermatitis	2.76e-06	9.56e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	2.75e-06	9.53e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	2.72e-06	9.44e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.72e-06	9.43e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.72e-06	9.42e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	2.72e-06	9.41e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	2.71e-06	9.4e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.71e-06	9.38e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL2—atopic dermatitis	2.71e-06	9.38e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	2.7e-06	9.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	2.69e-06	9.32e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	2.66e-06	9.23e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	2.66e-06	9.21e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.63e-06	9.13e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	2.62e-06	9.09e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	2.59e-06	8.99e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	2.59e-06	8.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.58e-06	8.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	2.52e-06	8.75e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL2—atopic dermatitis	2.51e-06	8.69e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—atopic dermatitis	2.49e-06	8.64e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—atopic dermatitis	2.48e-06	8.58e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	2.47e-06	8.57e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	2.47e-06	8.55e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	2.39e-06	8.3e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	2.39e-06	8.28e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	2.37e-06	8.21e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL2—atopic dermatitis	2.36e-06	8.19e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	2.35e-06	8.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.35e-06	8.15e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	2.35e-06	8.13e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.34e-06	8.11e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	2.33e-06	8.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	2.31e-06	8e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	2.31e-06	7.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.3e-06	7.98e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—atopic dermatitis	2.29e-06	7.93e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	2.28e-06	7.89e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—atopic dermatitis	2.26e-06	7.85e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	2.25e-06	7.81e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	2.23e-06	7.72e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	2.18e-06	7.54e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.14e-06	7.41e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	2.13e-06	7.38e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	2.12e-06	7.34e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	2.11e-06	7.3e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	2.08e-06	7.22e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.05e-06	7.1e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	2.01e-06	6.97e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARA—atopic dermatitis	2e-06	6.93e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	1.96e-06	6.79e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	1.94e-06	6.73e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	1.93e-06	6.69e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	1.92e-06	6.66e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—atopic dermatitis	1.92e-06	6.66e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	1.91e-06	6.63e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.89e-06	6.53e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	1.88e-06	6.51e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.87e-06	6.48e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—atopic dermatitis	1.85e-06	6.43e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	1.85e-06	6.41e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	1.85e-06	6.4e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—atopic dermatitis	1.85e-06	6.4e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	1.84e-06	6.36e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	1.79e-06	6.22e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	1.79e-06	6.19e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	1.77e-06	6.13e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	1.77e-06	6.12e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	1.76e-06	6.09e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	1.71e-06	5.92e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	1.7e-06	5.91e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	1.7e-06	5.89e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	1.68e-06	5.81e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-06	5.8e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-06	5.78e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	1.66e-06	5.76e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	1.65e-06	5.73e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	1.65e-06	5.71e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	1.64e-06	5.69e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—atopic dermatitis	1.63e-06	5.64e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	1.63e-06	5.64e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—atopic dermatitis	1.62e-06	5.62e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—atopic dermatitis	1.6e-06	5.55e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—atopic dermatitis	1.6e-06	5.54e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.6e-06	5.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	1.59e-06	5.53e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—atopic dermatitis	1.59e-06	5.52e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—atopic dermatitis	1.59e-06	5.51e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—atopic dermatitis	1.59e-06	5.51e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	1.59e-06	5.5e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	1.58e-06	5.48e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—atopic dermatitis	1.57e-06	5.45e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	1.57e-06	5.44e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	1.57e-06	5.43e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	1.56e-06	5.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.53e-06	5.29e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	1.5e-06	5.2e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-06	5.11e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—atopic dermatitis	1.47e-06	5.1e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-06	5.1e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-06	5.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	1.46e-06	5.07e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	1.46e-06	5.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.45e-06	5.03e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.45e-06	5.02e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.44e-06	5.01e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.39e-06	4.82e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—atopic dermatitis	1.34e-06	4.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.34e-06	4.65e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.33e-06	4.61e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	1.25e-06	4.34e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.23e-06	4.27e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.13e-06	3.91e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.09e-06	3.78e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.08e-06	3.76e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.05e-06	3.66e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.04e-06	3.6e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—atopic dermatitis	9.57e-07	3.32e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—atopic dermatitis	9.42e-07	3.26e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—atopic dermatitis	9.4e-07	3.26e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—atopic dermatitis	9.37e-07	3.25e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—atopic dermatitis	9.34e-07	3.24e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—atopic dermatitis	9.25e-07	3.21e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	9.22e-07	3.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	8.57e-07	2.97e-05	CbGpPWpGaD
